Apolipoprotein E polymorphism and low density lipoprotein (LDL) oxidation in patients with dementia

Folia Neuropathologica

Volumn 41, Issue 2, 2003, Pages 65-68

  Wehr, Hanna ^a   Bednarska Makaruk, Małgorzata ^a   Graban, Ałlstrok a ^a   Kunicki, Paweł K ^b   Łojkowska, Wanda ^a   Rodo, Maria ^a   Ryglewicz, Danuta ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Apolipoprotein E; Dementia; LDL oxidation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; ISOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE AMPLIFICATION; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OXIDATION; PROTEIN POLYMORPHISM; PROTEIN RESTRICTION; VITAMIN BLOOD LEVEL;

EID: 0041869242     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J (1994) Beta-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer disease. Biochem Biophys Res Commun, 200: 710-715.
2. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun, 6: 67-75.
3. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest, 34: 1345-1353.
4. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res, 31: 545-548.
5. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects of cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genetics, 14: 55-61.
6. Nikkila M, Pitkajarvi T, Koivula T, Solakivi T, Lehtimaki T, Laippala P, Jokela H, Lehtomaki E, Seppa K, Silanaukee P (1996) Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis, 119: 181-190.
7. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci, 13: 817-827.
8. Retz W, Gsell W, Munch G, Rosler M, Riederer P (1998) Free radicals in Alzheimer's diseases. J Neural Transm Suppl, 54: 221-236.
9. Ryglewicz D, Rodo M, Kunicki PK, Bednarska-Makaruk M, Graban A, Łojkowska W, Wehr H (2002) Plasma antioxidant activity and vascular dementia. J Neurol Sci, 203-204: 195-197.
10. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martrins MC, Sans S, Sass C, Visvikis S, De Backer G, Siest G (2000) Apolipoprotein E serum concentration and polymorphism in six European countries: The ApoEurope Project. Atherosclerosis, 152: 475-488.
11. Smith JD, Miyata M, Poulin SE, Neveux LM, Craig WY (1998) The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res, 28: 116-121.
12. Tamaoka A, Miyatake F, Matsuno S, Ishii K, Nagase S, Sahara N, Ono S, Mori H, Wakabayashi K, Tsuji S, Takahashi H, Shoi S (2000) Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer disease. Neurology, 54: 2319-2321.
13. Tribble DL, Holl LG, Wood PD, Krauss RM (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis, 93: 189-199.
14. Wehr H, Parnowski T, Puzyński S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wołkowska M (2000) Apolipoprotein E genotype and lipid and lipoprotein levels in dementia. Dement Geriatr Cogn, 11: 70-73.